BSECompany Update▲ Positive23 Jun 2026
Goldline Pharmaceutical Ltd
Disclosure under regulation 29 (2) of SEBI (SAST) Regulations, 2011
Goldline Pharmaceutical Ltd announced that its Promoter and Whole Time Director, Mr. Swapan Khandelwal, acquired 60,000 equity shares, representing 0.62% of the total paid-up share capital, through open market purchases on June 22, 2026. This disclosure was made under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Read more →📎 1 attachment